Featured Research

from universities, journals, and other organizations

Anorexia Nervosa Often Chronic, Study Finds

Date:
June 24, 2004
Source:
University Of Toronto
Summary:
Women who have been treated for anorexia nervosa remain at significant risk for relapse up to two years after their weight has been restored and they have been discharged from hospital, says a study from the University of Toronto and Toronto General Hospital.

Women who have been treated for anorexia nervosa remain at significant risk for relapse up to two years after their weight has been restored and they have been discharged from hospital, says a study from the University of Toronto and Toronto General Hospital.

Dr. Jacqueline Carter, a psychiatry professor at U of T and a staff psychologist in the hospital's eating disorders program, led the follow-up study of 51 patients, published in the May issue of Psychological Medicine.

It found that within two years of leaving the hospital, 35 per cent of the women had relapsed into anorexia - defined as a drop in body mass index (a measure of body fat based on height and weight) below 17.5 for three consecutive months. The mean time before relapse was 18 months, in contrast to earlier research which had suggested that those who relapsed would do so within a year of finishing treatment.

"Our most important finding is that in a significant proportion of cases, the illness is chronic and debilitating," says Carter. "We're pretty good at helping people to become weight-restored in the hospital, but really the challenge now is to figure out how to improve relapse prevention treatments and improve long-term outcomes for people with anorexia nervosa."

Excessive exercise immediately following discharge from the hospital was the strongest predictor of relapse, but previous suicide attempts, obsessive-compulsive symptoms and an overconcern about weight and shape were also important factors. This knowledge about predictors, and continuing research, will be used to develop treatments to help prevent relapse for a disease that affects one to two per cent of adult women sometime in their lifetimes, says Carter.

The study was funded by the Canadian Institutes of Health Research.


Story Source:

The above story is based on materials provided by University Of Toronto. Note: Materials may be edited for content and length.


Cite This Page:

University Of Toronto. "Anorexia Nervosa Often Chronic, Study Finds." ScienceDaily. ScienceDaily, 24 June 2004. <www.sciencedaily.com/releases/2004/06/040624093107.htm>.
University Of Toronto. (2004, June 24). Anorexia Nervosa Often Chronic, Study Finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2004/06/040624093107.htm
University Of Toronto. "Anorexia Nervosa Often Chronic, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2004/06/040624093107.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins